胶质瘤患者术后癫痫与生存:2009至2018年全国性人群队列研究
基于丹麦神经肿瘤登记处2009至2018年3763例组织病理学诊断的II、III、IV级胶质瘤患者,采用Cox比例风险模型分析术后癫痫与死亡风险的关系。术后癫痫患者死亡风险升高(HR=4.03,95%CI 2.69-6.03),术后新发癫痫患者(HR=2.08,95%CI 1.26-3.44)及IV级术后新发癫痫亚组(HR=1.83,95%CI 1.05-3.21)也见类似升高。作者认为术后癫痫可能负面影响胶质瘤诊断后的生存,可能是原发肿瘤治疗后胶质瘤更具侵袭性生长模式的表现。
要点
- 术后癫痫患者死亡风险升高(HR=4.03,95%CI 2.69-6.03),不论术前癫痫状态如何。
- 术后新发癫痫患者死亡风险升高(HR=2.08,95%CI 1.26-3.44)。
- IV级术后新发癫痫亚组死亡风险升高(HR=1.83,95%CI 1.05-3.21)。
核心结论
- 术后癫痫可能负面影响胶质瘤诊断后的生存,不论术前癫痫状态如何。
- 术后癫痫可能是原发肿瘤治疗后胶质瘤更具侵袭性生长模式的表现。
研究设计与样本
- 基于丹麦神经肿瘤登记处的全国性人群队列研究,纳入2009至2018年组织病理学诊断的II、III、IV级胶质瘤患者3763例。
- 癫痫诊断信息取自丹麦国家患者登记处、国家处方登记处和丹麦神经肿瘤登记处。
- 采用Cox比例风险模型计算95%置信区间(CI)的风险比(HR),分析术后癫痫与死亡风险的关联。
- 在三个不同样本中考察癫痫时机的作用:所有术后癫痫的胶质瘤患者、术后新发癫痫患者、以及仅IV级术后新发癫痫患者的同质亚组。
主要发现
- 术后癫痫的胶质瘤患者死亡风险升高,不论术前癫痫状态如何(HR=4.03;95%CI 2.69-6.03)。
- 术后新发癫痫患者也见类似的死亡风险升高(HR=2.08;95%CI 1.26-3.44)。
- IV级术后新发癫痫亚组也见死亡风险升高(HR=1.83;95%CI 1.05-3.21)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Postoperative epilepsy is common in glioma patients and has been suggested to indicate disease progression, yet knowledge of its role as a prognostic factor is limited. This study investigates the association between postoperative epilepsy and survival amongst patients with gliomas. METHODS: We included 3763 patients with histopathologically diagnosed grade II, III, and IV gliomas from 2009 to 2018 according to the Danish Neuro-Oncology Registry. Information on epilepsy diagnosis was redeemed from the Danish National Patient Registry, the National Prescription Registry and the Danish Neuro-Oncology Registry. We used Cox proportional hazards models with 95% confidence intervals (CIs) to examine hazard ratios (HRs) for the association between postoperative epilepsy and risk of death. We examined the role of the timing of epilepsy in three different samples: Firstly, in all glioma patients with postoperative epilepsy; secondly, in patients with postoperative de novo epilepsy; thirdly, exclusively in a homogeneous sub-group of grade IV patients with postoperative de novo epilepsy. RESULTS: Glioma patients with postoperative epilepsy had an increased risk of death, regardless of prior epilepsy status (HR = 4.03; CI 2.69-6.03). A similar increase in the risk of death was also seen in patients with postoperative de novo epilepsy (HR = 2.08; CI 1.26-3.44) and in the sub-group of grade IV patients with postoperative de novo epilepsy (HR = 1.83; CI 1.05-3.21). CONCLUSIONS: Postoperative epilepsy may negatively impact survival after glioma diagnosis, regardless of preoperative epilepsy status. Postoperative epilepsy may be an expression of a more invasive growth pattern of the gliomas following primary tumor treatment.
引用
- Marku M, Rasmussen BK, Belmonte F, et al. Postoperative epilepsy and survival in glioma patients: a nationwide population-based cohort study from 2009 to 2018. J Neurooncol. 2022. PMID: 35089480. doi:10.1007/s11060-022-03948-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。